dc.contributor |
University of Aberdeen.Applied Medicine |
|
dc.contributor |
University of Aberdeen.Medical Sciences - Cardiovascular Group |
|
dc.contributor |
University of Aberdeen.Institute of Medical Sciences |
|
dc.contributor |
University of Aberdeen.Clinical Medicine |
|
dc.creator |
van der Velden, Jolanda |
|
dc.creator |
Gabriele Tocchetti, Carlo |
|
dc.creator |
Varricchi, Gilda |
|
dc.creator |
Bianco, Anna |
|
dc.creator |
Sequeira, Vasco |
|
dc.creator |
Hilfiker-Kleiner, Denise |
|
dc.creator |
Hamdani, Nazha |
|
dc.creator |
Leite-Moreira, Adelino |
|
dc.creator |
Mayr, Manuel |
|
dc.creator |
Falcão-Pires, Ines |
|
dc.creator |
Thum, Thomas |
|
dc.creator |
Dawson, Dana K |
|
dc.creator |
Balligand, Jean-Luc |
|
dc.creator |
Heymans, Stephane |
|
dc.date |
2018-06-25T14:46:09Z |
|
dc.date |
2018-06-25T14:46:09Z |
|
dc.date |
2018-08-01 |
|
dc.date.accessioned |
2022-05-24T06:07:58Z |
|
dc.date.available |
2022-05-24T06:07:58Z |
|
dc.identifier |
van der Velden , J , Gabriele Tocchetti , C , Varricchi , G , Bianco , A , Sequeira , V , Hilfiker-Kleiner , D , Hamdani , N , Leite-Moreira , A , Mayr , M , Falcão-Pires , I , Thum , T , Dawson , D K , Balligand , J-L & Heymans , S 2018 , ' Metabolic changes in hypertrophic cardiomyopathies : Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology ' , Cardiovascular Research , vol. 114 , no. 10 , pp. 1273-1280 . https://doi.org/10.1093/cvr/cvy147 |
|
dc.identifier |
0008-6363 |
|
dc.identifier |
PURE: 125465877 |
|
dc.identifier |
PURE UUID: 3360b15c-730e-43c5-8629-9c51143e0fd4 |
|
dc.identifier |
PubMed: 29912308 |
|
dc.identifier |
Scopus: 85055042436 |
|
dc.identifier |
http://hdl.handle.net/2164/10659 |
|
dc.identifier |
https://doi.org/10.1093/cvr/cvy147 |
|
dc.identifier |
114 |
|
dc.identifier |
10 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/117755 |
|
dc.description |
JV is supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2014-40 DOSIS. SH has received funding from the European Union Commission’s Seventh Framework programme under grant agreement N° 305507 (HOMAGE), N° 602904 (FIBROTARGETS) and FP7-Health-2013- Innovations-1 N° 602156 (HECATOS). . We acknowledge the support from the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2011-ARENA, CVON2016-Early HFPEF, and ShePREDICTS. This research is cofinanced as a PPP-allowance Research and Innovation by the Ministry of Economic Affairs within Top Sector Life sciences & Health. This research was co-funded by the C3 project “Vision Core Leuven” of the Leuven University |
|
dc.description |
Peer reviewed |
|
dc.description |
Publisher PDF |
|
dc.format |
8 |
|
dc.format |
application/pdf |
|
dc.language |
eng |
|
dc.relation |
Cardiovascular Research |
|
dc.rights |
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
|
dc.subject |
SDG 3 - Good Health and Well-being |
|
dc.subject |
Journal Article |
|
dc.subject |
hypertrophic cardiomyopathy |
|
dc.subject |
mutations |
|
dc.subject |
metabolism |
|
dc.subject |
R Medicine |
|
dc.subject |
R |
|
dc.title |
Metabolic changes in hypertrophic cardiomyopathies : Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology |
|
dc.type |
Journal article |
|